Please provide your email address to receive an email when new articles are posted on . In the U.S. market, we currently have three newer multifocal IOLs approved for use: the Alcon Clareon PanOptix ...
An enhanced monofocal IOL provided useful near and intermediate vision and “excellent” distance vision, according to a study ...
FORT WORTH, Texas--(BUSINESS WIRE)-- Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced results from a new study presented at the ...
GENEVA--(BUSINESS WIRE)-- Alcon, the global leader in eye care dedicated to helping people see brilliantly, today proudly announced that more than 175 million of its intraocular lenses (IOLs) have ...
New Delhi: Johnson & Johnson announced today that it is expanding its portfolio of presbyopia-correcting intraocular lenses (PC-IOL) with the roll-out of TECNIS Odyssey IOL in India. The new full ...
Vivity complements Alcon’s existing IOL portfolio by providing an additional option for cataract patients to treat presbyopia A first-of-its-kind, non-diffractive lens that offers a continuous ...
VAUGHAN, Ontario--(BUSINESS WIRE)-- Bausch + Lomb Corporation (BLCO:CA), a leading global eye health company dedicated to helping people see better to live better, today announced CE Mark approval for ...